TRANSMEDICS GROUP, INC.
200 Minuteman Road
Andover, Massachusetts 01810
May 19, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington, D.C. 20549
| Attention: | Paul Fischer; Mary Beth Breslin |
| Re: | TransMedics Group, Inc. Registration Statement on Form S-3 (File No. 333-238052) |
| Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, TransMedics Group, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-238052) (the “Registration Statement”), so that it will be declared effective at 4:30 p.m. Eastern Time on May 21, 2020, or as soon as possible thereafter. The Company hereby authorizes Tara Fisher, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Tara Fisher of Ropes & Gray LLP, counsel to the Company, at (617) 235-4824.
| Very truly yours,
TRANSMEDICS GROUP, INC. | ||
| By: | /s/ Stephen Gordon | |
| Stephen Gordon Chief Financial Officer, Treasurer and Secretary | ||